University of Maryland School of Medicine

NIH Awards $13.7 Million Grant to Recruit Underrepresented Groups as New Faculty

How Memory of Personal Interactions Declines with Age

University of Maryland School of Medicine Study Identifies Target for Potentially Developing New Therapies to Treat Age-Related Cognitive Decline

UM School of Medicine Researchers Find Blood Type Linked to Risk of Stroke Before Age 60

Research Could Lead to Potential New Ways to Prevent Strokes in Young Adults

Effects of Drugs in Mice can Depend on the Sex of the Human Experimenter

University of Maryland School of Medicine researchers demonstrated that a stress response in the brain is essential for ketamine’s antidepressant response in mice suggesting new ways to improve antidepressant therapy for patients who do not respond to the treatment

$800K Donation Will Fund New Discoveries and Treatments for ALS

Donation from Blazeman Foundation for ALS Could Lead to Potential New Discoveries and Treatment for Amyotrophic Lateral Sclerosis

UM School of Medicine Study Finds a New Way to Optimize Treatment Success for Fecal Transplants

Findings Could Lead to Treatments for a Variety of Conditions

Senior Academic Leader and Internationally Recognized Scientist Christopher P. O'Donnell, PhD, Appointed Vice Dean for Research Development and Operations at UM School of Medicine

In His New Role, Dr. O’Donnell Will Oversee UMSOM’s Broad Research Enterprise; Continue to Advance School’s Position as Global Leader in Biomedical Research

Gene Mutations from Patients with Debilitating Seizure and Movement Disorder Created in Mice

University of Maryland School of Medicine Study Findings Provide a New Understanding of the Disease Mechanism and Treatment Options

New Study Confirms Typhoid Vaccine Safety, Immune Response in Children

Vaccine does not interfere with routine measles-rubella vaccine in Malawian children

New Study Finds Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against Omicron Subvariant BA.5

Two UMSOM faculty members are investigators on research that is likely to inform future decision making on COVID-19 boosters